One of Canada’s largest cannabis companies is surging after getting approval to export new products to Germany (TLRY)
- Tilray
- Watch Tilray trade in real time here
Shares of Tilray surged as much as 9% in premarket trading on Thursday after the Canadian medical-cannabis producer said it had received regulatory approval to export more products to Germany.
Tilray's medical-cannabis oil was already on shelves in German pharmacies. The company will soon be able to sell its whole-flower products in addition, making it the only producer that sells both types in Germany.
In a statement, Tilray said some patients who require medical cannabis with a higher potency will have access to this kind of treatment for the first time.
Tilray's shares have surged over 500% since they went public in July. For the second quarter, the company reported
Tilray said it would release details on how patients in Germany can access its whole-flower products later this year.
Now read:
- A fund manager who's crushing nearly all of her peers breaks down 3 under-the-radar stocks driving her strong performance
- Wall Street is turning its back on a crucial part of the tech industry — and it's threatening to tank stocks across the entire sector
- Oracle's head of cloud left after butting heads with Larry Ellison, source says